Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Institutional Investor > Versant Venture Management, Llc > Profile

Instuitional Investor - Versant Venture Management, Llc

Profile
13F Holdings

Fund Profile

Filing Period:

Fund Name:	Versant Venture Management, Llc
Portfolio Value	$151,060,501

Top 13F Holdings

Filing Period:

No.	Security	Ticker	Shares	Value	% Port
1.	Monte Rosa Therapeutics Inc.	GLUE	4,382,687	$68,720,532	45.49%
2.	Lenz Therapeutics Inc.	LENZ	2,656,888	$42,510,208	28.14%
3.	Jade Biosciences Inc.	JBIO	1,525,820	$23,543,403	15.59%
4.	Crispr Therapeutics Ag	CRSP	148,831	$7,804,698	5.17%
5.	Contineum Therapeutics Inc.	CTNM	542,628	$6,202,238	4.11%